|
RFC4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.476000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.294400E-01 |
| Normal-vs-Stage2 |
1.304610E-01 |
| Normal-vs-Stage3 |
6.439200E-01 |
| Normal-vs-Stage4 |
8.975200E-01 |
| Stage1-vs-Stage2 |
5.180300E-02 |
| Stage1-vs-Stage3 |
6.519600E-01 |
| Stage1-vs-Stage4 |
9.339200E-01 |
| Stage2-vs-Stage3 |
1.441010E-01 |
| Stage2-vs-Stage4 |
8.946400E-02 |
| Stage3-vs-Stage4 |
6.912400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.018600E-01 |
| Normal-vs-AfricanAmerican |
8.549200E-01 |
| Normal-vs-Asian |
4.907000E-01 |
| Caucasian-vs-AfricanAmerican |
8.844800E-01 |
| Caucasian-vs-Asian |
2.431000E-01 |
| AfricanAmerican-vs-Asian |
3.856600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.516600E-01 |
| Normal-vs-Female |
6.601600E-01 |
| Male-vs-Female |
9.349800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.836600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.927600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.230600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.788800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.383700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.506000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.434000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.017400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.606000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.711800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.009000E-01 |
| Classical-VS-Follicular |
5.73739999999434E-05 |
| Classical-VS-Other |
1.716010E-01 |
| Classical-VS-Normal |
7.425800E-01 |
| Tall-VS-Follicular |
2.716300E-03 |
| Tall-VS-Other |
1.518030E-01 |
| Tall-VS-Normal |
7.134200E-01 |
| Follicular-VS-Other |
8.652400E-01 |
| Follicular-VS-Normal |
2.206500E-02 |
| Other-VS-Normal |
4.033400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.376000E-01 |
| Normal-vs-N1 |
8.241000E-01 |
| N0-vs-N1 |
6.153400E-01 |
|
|
